Reframing BALF liquid biopsy: Defining the BALF–plasma continuum for molecular diagnosis and early lung cancer management

dc.contributor.authorVeerasatian T.
dc.contributor.authorRattanapitoon S.K.
dc.contributor.authorThanchonnang C.
dc.contributor.authorRattanapitoon N.K.
dc.contributor.correspondenceVeerasatian T.
dc.contributor.otherMahidol University
dc.date.accessioned2025-10-24T18:16:02Z
dc.date.available2025-10-24T18:16:02Z
dc.date.issued2025-11-01
dc.identifier.citationLung Cancer Vol.209 (2025)
dc.identifier.doi10.1016/j.lungcan.2025.108794
dc.identifier.eissn18728332
dc.identifier.issn01695002
dc.identifier.scopus2-s2.0-105018883410
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/112735
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleReframing BALF liquid biopsy: Defining the BALF–plasma continuum for molecular diagnosis and early lung cancer management
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105018883410&origin=inward
oaire.citation.titleLung Cancer
oaire.citation.volume209
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationFMC Medical Center
oairecerif.author.affiliationBuriram Hospital

Files

Collections